FdaApplication
ANDA 212779
Identifiers
- fda_app_no: ANDA212779
Properties
| Property | Value |
|---|---|
| applicant_name | ANI PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-01-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CITRATE | POTASSIUM CITRATE | 10MEQ | TABLET, EXTENDED RELEASE;ORAL |
| POTASSIUM CITRATE | POTASSIUM CITRATE | 15MEQ | TABLET, EXTENDED RELEASE;ORAL |
2 products